Cargando…
The immunosuppressant 15-deoxyspergualin [correction of 1,5- deoxyspergualin] reveals commonality between preT and preB cell differentiation
15 [correction of 1,5] deoxyspergualin (DSG) is a potent immunosuppressant whose mechanism of action is still somewhat of a mystery. We have studied the generation of lymphocytes in mice treated with this drug. The differentiation of T cells in the thymus was blocked at an important early control po...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192603/ https://www.ncbi.nlm.nih.gov/pubmed/8676063 |
Ejemplares similares
-
Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study
por: Lorenz, Hanns-Martin, et al.
Publicado: (2011) -
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
por: Ishida, Hideki, et al.
Publicado: (2008) -
Cytostatic Effect of Deoxyspergualin on a Murine Leukemia Cell Line L1210
por: Hiratsuka, Masaharu, et al.
Publicado: (1991) -
PreB cells are moving on
por: Dixit, Dhaval, et al.
Publicado: (2018) -
Myeloprotective Activity of Deoxyspergualin: Influence on Splenic Colony‐forming Cell Injury and Antitumor Activity of Mitomycin C in Mice
por: Nemoto, Kyuichi, et al.
Publicado: (1992)